Sanofi Sues Lilly over Generic Insulin

Jul 09, 2014


Sanofi filed a lawsuit against Eli Lilly accusing the company of infringing seven patents related to insulin and delivery devices. According to a Reuters article, Sanofi is seeking to halt Lilly's proposed commercial marketing in the United States of a rival treatment to Sanofi's Lantus, known as Abasria, saying the sale would violate its rights.

Lilly spokeswoman Tammy Hull said the Indianapolis-based company is reviewing Sanofi's latest lawsuit, and "does not believe the application infringes any of the asserted patents." Read the full story

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments